The reality of complexity: concomitant genomic alterations in patients with EGFR mutations

被引：2

作者：

Cardona, Andres F. ^{[1
,2
,3
]}

Lucia Zatarain-Barron, Zyanya ^{[4
,5
]}

Rojas, Leonardo ^{[1
,2
,6
]}

Arrieta, Oscar ^{[4
,5
]}

机构：

[1] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia

[2] Fdn Clin & Appl Canc Res FICMAC, Calle 116 9-72,C 318, Bogota, Colombia

[3] Univ Bosque, Clin Res & Biol Syst Dept, Bogota, Colombia

[4] Inst Nacl Cancerol INCan, Thorac Oncol Unit, Mexico City, DF, Mexico

[5] Inst Nacl Cancerol INCan, Lab Personalized Med, Mexico City, DF, Mexico

[6] Sanitas Fdn, Clin Colsanitas, Oncol Dept, Bogota, Colombia

来源：

JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 02期

关键词：

CELL LUNG-CANCER; ACQUIRED-RESISTANCE; EVOLUTION; HETEROGENEITY; CHEMOTHERAPY; INHIBITORS; THERAPY; IMPACT; GENES; KRAS;

D O I：

10.21037/jtd.2017.12.136

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：597 / 599

页数：3

共 17 条

[1] The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer
Arrieta, Oscar
Felipe Cardona, Andres
Corrales, Luis
Delia Campos-Parra, Alma
Sanchez-Reyes, Roberto
Amieva-Rivera, Eduardo
Rodriguez, July
Vargas, Carlos
Carranza, Hernan
Otero, Jorge
Karachaliou, Nikki
Astudillo, Horacio
Rosell, Rafael
[J]. LUNG CANCER, 2015, 87 (02) : 169 - 175
[2] Arrieta O, 2013, REV INVEST CLIN, V65, pS5
[3] Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Blakely, Collin M.
Watkins, Thomas B. K.
Wu, Wei
Gini, Beatrice
Chabon, Jacob J.
McCoach, Caroline E.
McGranahan, Nicholas
Wilson, Gareth A.
Birkbak, Nicolai J.
Olivas, Victor R.
Rotow, Julia
Maynard, Ashley
Wang, Victoria
Gubens, Matthew A.
Banks, Kimberly C.
Lanman, Richard B.
Caulin, Aleah F.
St John, John
Cordero, Anibal R.
Giannikopoulos, Petros
Simmons, Andrew D.
Mack, Philip C.
Gandara, David R.
Husain, Hatim
Doebele, Robert C.
Riess, Jonathan W.
Diehn, Maximilian
Swanton, Charles
Bivona, Trever G.
[J]. NATURE GENETICS, 2017, 49 (12) : 1693 - +
[4] KRAS Mutation as the Biomarker of Response to Chemotherapy and EGFR-TKIs in Patients With Advanced Non-Small Cell Lung Cancer Clues For Its Potential Use in Second-Line Therapy Decision Making
Campos-Parra, Alma D.
Zuloaga, Carlos
Vazquez Manriquez, Maria Eugenia
Aviles, Alejandro
Borbolla-Escoboza, Jose
Cardona, Andres
Meneses, Abelardo
Arrieta, Oscar
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 33 - 40
[5] Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
Canale, Matteo
Petracci, Elisabetta
Delmonte, Angelo
Chiadini, Elisa
Dazzi, Claudio
Papi, Maximilian
Capelli, Laura
Casanova, Claudia
De Luigi, Nicoletta
Mariotti, Marita
Gamboni, Alessandro
Chiari, Rita
Bennati, Chiara
Calistri, Daniele
Ludovini, Vienna
Crino, Lucio
Amadori, Dino
Ulivi, Paola
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2195 - 2202
[6] Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, Emily
Di Nicolantonio, Federica
Loupakis, Fotios
Bardelli, Alberto
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) : 472 - 484
[7] Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
de Bruin, Elza C.
McGranahan, Nicholas
Mitter, Richard
Salm, Max
Wedge, David C.
Yates, Lucy
Jamal-Hanjani, Mariam
Shafi, Seema
Murugaesu, Nirupa
Rowan, Andrew J.
Groenroos, Eva
Muhammad, Madiha A.
Horswell, Stuart
Gerlinger, Marco
Varela, Ignacio
Jones, David
Marshall, John
Voet, Thierry
Van Loo, Peter
Rassl, Doris M.
Rintoul, Robert C.
Janes, Sam M.
Lee, Siow-Ming
Forster, Martin
Ahmad, Tanya
Lawrence, David
Falzon, Mary
Capitanio, Arrigo
Harkins, Timothy T.
Lee, Clarence C.
Tom, Warren
Teefe, Enock
Chen, Shann-Ching
Begum, Sharmin
Rabinowitz, Adam
Phillimore, Benjamin
Spencer-Dene, Bradley
Stamp, Gordon
Szallasi, Zoltan
Matthews, Nik
Stewart, Aengus
Campbell, Peter
Swanton, Charles
[J]. SCIENCE, 2014, 346 (6206) : 251 - 256
[8] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, Marco
Rowan, Andrew J.
Horswell, Stuart
Larkin, James
Endesfelder, David
Gronroos, Eva
Martinez, Pierre
Matthews, Nicholas
Stewart, Aengus
Tarpey, Patrick
Varela, Ignacio
Phillimore, Benjamin
Begum, Sharmin
McDonald, Neil Q.
Butler, Adam
Jones, David
Raine, Keiran
Latimer, Calli
Santos, Claudio R.
Nohadani, Mahrokh
Eklund, Aron C.
Spencer-Dene, Bradley
Clark, Graham
Pickering, Lisa
Stamp, Gordon
Gore, Martin
Szallasi, Zoltan
Downward, Julian
Futreal, P. Andrew
Swanton, Charles
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) : 883 - 892
[9] Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
Hu, Wentao
Liu, Yahui
Chen, Jian
[J]. ONCOTARGET, 2017, 8 (15) : 25046 - 25054
[10] Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, Michael S.
Stojanov, Petar
Polak, Paz
Kryukov, Gregory V.
Cibulskis, Kristian
Sivachenko, Andrey
Carter, Scott L.
Stewart, Chip
Mermel, Craig H.
Roberts, Steven A.
Kiezun, Adam
Hammerman, Peter S.
McKenna, Aaron
Drier, Yotam
Zou, Lihua
Ramos, Alex H.
Pugh, Trevor J.
Stransky, Nicolas
Helman, Elena
Kim, Jaegil
Sougnez, Carrie
Ambrogio, Lauren
Nickerson, Elizabeth
Shefler, Erica
Cortes, Maria L.
Auclair, Daniel
Saksena, Gordon
Voet, Douglas
Noble, Michael
DiCara, Daniel
Lin, Pei
Lichtenstein, Lee
Heiman, David I.
Fennell, Timothy
Imielinski, Marcin
Hernandez, Bryan
Hodis, Eran
Baca, Sylvan
Dulak, Austin M.
Lohr, Jens
Landau, Dan-Avi
Wu, Catherine J.
Melendez-Zajgla, Jorge
Hidalgo-Miranda, Alfredo
Koren, Amnon
McCarroll, Steven A.
Mora, Jaume
Lee, Ryan S.
Crompton, Brian
Onofrio, Robert
[J]. NATURE, 2013, 499 (7457) : 214 - 218

← 1 2 →